for a summary of our marketed products and clinical development programs. Since our incorporation in January 2012, our operations to date have included organizing and staffing our company, business planning, raising capital, developing our compounds, engaging in other discovery and preclinical activities, the commercial launches of AUVELITY and SUNOSI, and preparatory activities for the launch of SYMBRAVO. Subsequent to our IPO, we financed our operations primarily through proceeds from sales of...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-23 | 2025-12-31 | 0001193125-26-064267 | EDGAR | 107K words |
| 2025-02-18 | 2024-12-31 | 0000950170-25-022457 | EDGAR | — |
| 2024-02-23 | 2023-12-31 | 0000950170-24-019118 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-004728 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002568 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001564590-21-009924 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001558370-20-002573 | EDGAR | — |
| 2019-03-15 | 2018-12-31 | 0001558370-19-002068 | EDGAR | — |
| 2018-03-07 | 2017-12-31 | 0001558370-18-001639 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001558370-17-001426 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-03 | 2025-09-30 | 0001193125-25-262664 | EDGAR | 72K words |
| 2025-08-04 | 2025-06-30 | 0000950170-25-102148 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0000950170-25-063634 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124758 | EDGAR | — |
| 2024-08-05 | 2024-06-30 | 0000950170-24-090828 | EDGAR | — |
| 2024-05-06 | 2024-03-31 | 0000950170-24-053697 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0000950170-23-059470 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039178 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-018976 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022710 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016143 | EDGAR | — |
| 2022-05-02 | 2022-03-31 | 0000950170-22-006901 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-10 | 0001193125-26-341206 | EDGAR | — |
| 2026-07-15 | 0001193125-26-304039 | EDGAR | — |
| 2026-04-01 | 0001193125-26-135669 | EDGAR | 1K words |
| 2026-02-23 | 0001193125-26-062421 | EDGAR | — |
| 2026-02-17 | 0001193125-26-053009 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009744 | EDGAR | — |
| 2025-12-31 | 0001193125-25-337644 | EDGAR | — |
| 2025-11-03 | 0001193125-25-261651 | EDGAR | — |
| 2025-08-20 | 0001579428-25-000007 | EDGAR | — |
| 2025-08-04 | 0000950170-25-101624 | EDGAR | — |
297 total filings indexed. 265 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001579428 |
| Ticker | AXSM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.axsome.com |
| Listed | 2015-11-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AXSM (~200 tokens, structured JSON with cryptographic provenance)